Kumar Singh Mansukh Mandaviya city New Delhi India city Pune covid-19 vaccine Health Kumar Singh Mansukh Mandaviya city New Delhi India city Pune

Serum Institute writes to Union Health Minister proposing reforms in drug regulatory system

Reading now: 410

NEW DELHI : World's largest vaccine manufacturer by volume, Serum Institute of India (SII) has written to Union Health Minister Mansukh Mandaviya suggesting reforms in the existing drug regulatory system, including allowing manufacturing and stockpiling of non-Covid vaccines while undergoing clinical trial.

According to official sources, Prakash Kumar Singh, Director, Government and Regulatory Affairs at Pune-based SII, in a letter, referred to a gazette notification by the Union Health Ministry on May 18, 2020.

He said it allowed manufacturing and stockpiling of COVID-19 vaccine under clinical trial for marketing authorization for sale or distribution. "Because of this rule, it became possible for us to manufacture and stockpile the

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News